Clinical Trial Details
| Trial ID: | L4522 |
| Source ID: | NCT00871936 |
| Associated Drug: | Slx-4090 |
| Title: | A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: SLx-4090|OTHER: Placebo|DRUG: Metformin |
| Outcome Measures: | Primary: Reduction in HbA1c, 12 weeks | Secondary: Adverse Events, 12 weeks |
| Sponsor/Collaborators: | Sponsor: Response Pharmaceuticals |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 82 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2009-04 |
| Completion Date: | 2009-10 |
| Results First Posted: | |
| Last Update Posted: | 2023-11-18 |
| Locations: | Anaheim, California, 92801, United States|Burbank, California, 91505, United States|Los Angeles, California, 90036, United States|Los Angeles, California, 90057, United States|West Palm Beach, Florida, 33401, United States|Addison, Illinois, 60101, United States|Auburn, Maine, 04210, United States|Charlotte, North Carolina, 28211, United States|Hickory, North Carolina, 28602, United States|Winston-Salem, North Carolina, 27103, United States|Greenville, South Carolina, 29615, United States|San Antonio, Texas, 78229, United States |
| URL: | https://clinicaltrials.gov/show/NCT00871936 |
